COMPANY OVERVIEW

None

---

LOCATION

---

THERAPEUTIC AREAS

---

WEBSITE

None

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

PRESS RELEASES

Jan 31, 2023

Arugula Sciences announces FDA Approval to Proceed with Phase 1 Study of SIG002, a Perinatal-derived Secretome Product, for the Treatment of Big Toe Osteoarthritis (Hallux Rigidus)

Nov 13, 2020

Global Hallux Valgus (Bunion) Market Report 2020: Insight, Epidemiology and Market Forecast 2017-2030 - ResearchAndMarkets.com

Nov 8, 2016

Hallux Announces Start of Phase 2 Clinical Trial

Dec 16, 2015

Hallux Announces Closing of $7.1 Million Series A Financing

For More Press Releases

---